Scarica l'app Stockscreener
41.85
2.79%
-1.20
Dopo l'orario di chiusura:
41.85
Precedente Chiudi:
$43.05
Aprire:
$43.08
Volume 24 ore:
647.14K
Relative Volume:
0.68
Capitalizzazione di mercato:
$3.19B
Reddito:
-
Utile/perdita netta:
$-64.16M
Rapporto P/E:
-32.95
EPS:
-1.2702
Flusso di cassa netto:
$-69.06M
1 W Prestazione:
-5.87%
1M Prestazione:
+17.03%
6M Prestazione:
+106.97%
1 anno Prestazione:
+12.96%
Intervallo 1D:
$41.00
$43.80
Intervallo di 1 settimana:
$41.00
$45.56
Portata 52W:
$14.80
$45.56
Cg Oncology Inc Stock (CGON) Company Profile
Nome
Cg Oncology Inc
Settore
Industria
Telefono
(949) 419-6203
Indirizzo
400 SPECTRUM CENTER DRIVE, IRVINE
Confronta CGON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
41.85 | 3.27B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-08 | Iniziato | Guggenheim | Buy |
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-07-10 | Ripresa | Goldman | Buy |
| 2025-05-02 | Iniziato | JP Morgan | Overweight |
| 2025-04-16 | Iniziato | Scotiabank | Sector Perform |
| 2025-01-07 | Iniziato | TD Cowen | Buy |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-09-23 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-08-28 | Iniziato | ROTH MKM | Buy |
| 2024-06-28 | Iniziato | BofA Securities | Buy |
| 2024-02-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-20 | Iniziato | Goldman | Neutral |
| 2024-02-20 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-14 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Cg Oncology Inc Borsa (CGON) Ultime notizie
Short interest data insights for CG Oncology Inc.2025 Key Lessons & AI Driven Price Predictions - newser.com
Candlestick signals on CG Oncology Inc. stock todayEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
Guggenheim Initiates CG Oncology (CGON) Coverage with $90 PT, Highlights Bladder Cancer Therapeutic Cretostimogene - Yahoo
Leonard Post sells CG Oncology shares for $43,250 By Investing.com - Investing.com South Africa
Leonard Post sells CG Oncology shares for $43,250 - Investing.com
Why CG Oncology Inc. stock is rated strong buyTrade Exit Report & Consistent Profit Trading Strategies - newser.com
Can you recover from losses in CG Oncology Inc.Gap Up & Smart Allocation Stock Tips - newser.com
Why retail investors favor CG Oncology Inc. stockLayoff News & Accurate Buy Signal Notifications - newser.com
How to recover losses in CG Oncology Inc. stockJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
James Mulay Sells 5,903 Shares of CG Oncology (NASDAQ:CGON) Stock - MarketBeat
CG Oncology (NASDAQ:CGON) Research Coverage Started at Guggenheim - Defense World
CG Oncology (CGON) Is Up 8.6% After Analysts Spotlight Late-Stage Bladder Cancer Therapy Data – Has the Bull Case Changed? - Sahm
Midday Stock Roundup: EnVVeno down 15% - Orange County Business Journal
CG Oncology (NASDAQ:CGON) Reaches New 1-Year HighHere's What Happened - MarketBeat
CG Oncology (NASDAQ:CGON) Now Covered by Analysts at Guggenheim - MarketBeat
Is this a good reentry point in CG Oncology Inc.2025 Institutional Moves & Fast Gaining Stock Strategy Reports - newser.com
CG Oncology (NASDAQ:CGON) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
CG Oncology (CGON): Assessing Valuation Following Analyst Coverage and Positive Phase 3 Trial Results - Yahoo Finance
CG Oncology: Upgraded, Rising, But Should We Still Be Optimistic? (NASDAQ:CGON) - Seeking Alpha
CG Oncology’s Surging Prospects: Buy or Hold? - StocksToTrade
When is the best time to exit CG Oncology Inc.Stop Loss & Expert Verified Movement Alerts - newser.com
CG Oncology Inc. recovery potential after sell offJuly 2025 Decliners & Growth Oriented Trading Recommendations - newser.com
CG Oncology (CGON): Valuation in Focus After Analyst Coverage and Promising Cretostimogene Phase 3 Results - Sahm
Price momentum metrics for CG Oncology Inc. explainedJuly 2025 Price Swings & AI Based Buy and Sell Signals - newser.com
Ranking CG Oncology Inc. among high performing stocks via toolsLong Setup & Accurate Entry/Exit Alerts - newser.com
Why Cg Oncology Stock Rocketed 7% Higher Today - The Globe and Mail
CG Oncology (NASDAQ:CGON) Trading 7.1% HigherHere's What Happened - MarketBeat
CG Oncology stock initiated Buy at Guggenheim (CGON:NASDAQ) - Seeking Alpha
Guggenheim Initiates Coverage of CG Oncology (CGON) with Buy Recommendation - Nasdaq
Guggenheim Initiates Coverage on CG Oncology With Buy Rating, $90 Price Target - MarketScreener
CG Oncology, Inc. (CGON) Stock Analysis: 73% Potential Upside In The Biotech Sector - DirectorsTalk Interviews
CG Oncology Announces Promising Phase 3 Trial Results - MSN
Applying Elliott Wave Theory to CG Oncology Inc.Portfolio Profit Report & Verified Swing Trading Watchlists - newser.com
What’s next for CG Oncology Inc. stock priceProduct Launch & High Return Trade Opportunity Guides - newser.com
How CG Oncology Inc. stock reacts to bond yieldsQuarterly Profit Summary & Long-Term Capital Growth Ideas - newser.com
How to monitor CG Oncology Inc. with trend dashboardsJuly 2025 Update & Safe Entry Point Alerts - newser.com
Will a bounce in CG Oncology Inc. offer an exitJuly 2025 Institutional & Long-Term Investment Growth Plans - newser.com
How analysts rate CG Oncology Inc. stock today2025 Trade Ideas & Technical Confirmation Trade Alerts - newser.com
CG Oncology (NASDAQ:CGON) Upgraded to Hold at Wall Street Zen - Defense World
CG Oncology (NASDAQ:CGON) Raised to "Hold" at Wall Street Zen - MarketBeat
NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com
Best data tools to analyze CG Oncology Inc. stockQuarterly Trade Summary & Low Drawdown Trading Strategies - newser.com
Cg Oncology Inc Azioni (CGON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cg Oncology Inc Azioni (CGON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| POST LEONARD E | Director |
Oct 13 '25 |
Sale |
43.25 |
1,000 |
43,250 |
0 |
| Mulay James | Director |
Oct 09 '25 |
Option Exercise |
3.72 |
5,903 |
21,959 |
5,903 |
| Mulay James | Director |
Oct 09 '25 |
Sale |
43.99 |
5,903 |
259,673 |
0 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):